Block of Peripheral Nerves Infusion pumps and catheters are used to control postoperative discomfort. A nerve block uses an anesthetic to numb a bodily area after surgery in order to lessen discomfort. Nerve blocks aid in patients' quick recovery.
After surgery, a thin tube called a catheter is inserted under the skin to provide numbing medication to the area surrounding the nerves. Automatic medication delivery is provided via the infusion pump.
continuous peripheral nerve block (CPNB) catheters market research offers a detailed and comprehensive analysis of the global market, with a particular focus on future projections. The report is structured into various segments, each analyzing the factors and events that are likely to impact the market in the upcoming years.
Furthermore, the report includes Porter's Five Forces analysis that evaluates the competitive forces in the global market for Global continuous peripheral nerve block (CPNB) catheters market, such as the bargaining power of customers and suppliers, the threat of new entrants, the threat of substitutes, and the level of competition among existing competitors. Additionally, the report offers insights into the market dynamics, such as market drivers, challenges, and opportunities.
Market Size and Growth Rate:
According to the DataM market research report, the continuous peripheral nerve block catheters market size was valued at US$ 536.2 million in 2022 and is estimated to reach US$ 870.1 million by 2030, growing at a CAGR of 6.1% during the forecast period (2023-2030).
CPNB catheters market Drivers:
Postoperative opioid usage is often linked to foot and ankle surgery, and it has been shown to be linked to a number of postoperative problems. Continuous peripheral nerve blocks (CPNBs) are a secure and reliable approach to pain control for outpatient foot and ankle surgery, according to research published in Case Reports in Anesthesiology in 2021.
Additionally, studies comparing CPNBs with single-shot peripheral nerve blocks (PNB) have demonstrated that the need for rescue opioid usage after ambulatory orthopedic surgery is reduced with CPNBs. According to preliminary research, because to the increased risk of infection, continuous peripheral nerve block catheters should be withdrawn after 48 hours.
Market Restraints:
Over the projected period, an increasing number of product recalls is anticipated to restrain the development of the worldwide continuous peripheral nerve block catheter market.
For instance, in August 2018, B. Braun Medical Inc. voluntarily recalled a number of its products from the Canada market, including catheter connectors, nerve block sets, epidural catheter sets, epidural catheter trays, and epidural sets, due to a design flaw that could have resulted in the connector opening accidentally during use. In other circumstances, this has caused connection leaking or separation.
Market Key Players:
The major players are adopting several growth strategies, such as Type launches, acquisitions, and collaborations, contributing to the growth of the continuous peripheral nerve block catheters market globally.
- Ambu A/S
- Teleflex Incorporated
- B. Braun Melsungen AG
DataM Intelligence’s report on the continuous peripheral nerve block catheters market provides insights into the key drivers, challenges, top trends, and opportunities in the market. It also provides you with a geographical analysis and competitive landscape, which will paint a clear picture of the current market scenario.
To Gain deeper insights into the continuous peripheral nerve block catheters market and stay ahead of the competition, request a sample report from DataM Intelligence today.
To Know More Download Sample
